No significant news for in the past two years. LVTX is not currently paying a regular dividend. Actual Analyst Range Consensus View the latest LAVA Therapeutics N.V. (LVTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Is lava Therapeutics (lvtx) a good stock to buy?
LAVA Therapeutics N.V. (LVTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating.
How much did lava Therapeutics IPO cost?
LAVA Therapeutics (LVTX) raised $100 million in an initial public offering (IPO) on Thursday, March 25th 2021. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Jefferies and SVB Leerink acted as the underwriters for the IPO and Kempen & Co. was co-manager. How do I buy shares of LAVA Therapeutics?
